Soumit Roy
Stock Analyst at Jones Trading
(3.43)
# 985
Out of 5,124 analysts
44
Total ratings
32.35%
Success rate
12.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $2.42 | +189.26% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $1.47 | +376.19% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $4.77 | +109.64% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $3.56 | - | 1 | Oct 24, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $41.52 | +20.42% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $5.33 | +294.00% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $20.12 | +98.81% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $15.40 | +75.32% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $2.41 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.87 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $7.88 | +90.36% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.96 | +11.61% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $27.72 | +22.66% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $2.34 | +1,438.46% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.87 | +1,014.98% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.96 | +13.07% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $8.18 | +107.82% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.05 | +534.15% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $8.42 | +660.10% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.98 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.47 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $10.35 | +151.21% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $13.80 | +407.25% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $65.30 | -84.69% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.84 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $14.25 | +461.40% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.05 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $0.97 | +32,869.30% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.16 | +19,371.15% | 1 | Feb 24, 2021 |
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.42
Upside: +189.26%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $1.47
Upside: +376.19%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.77
Upside: +109.64%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.56
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $41.52
Upside: +20.42%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.33
Upside: +294.00%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $20.12
Upside: +98.81%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $15.40
Upside: +75.32%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.41
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.87
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.88
Upside: +90.36%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $8.96
Upside: +11.61%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $27.72
Upside: +22.66%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.34
Upside: +1,438.46%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.87
Upside: +1,014.98%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $7.96
Upside: +13.07%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $8.18
Upside: +107.82%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.05
Upside: +534.15%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $8.42
Upside: +660.10%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.98
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.47
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $10.35
Upside: +151.21%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $13.80
Upside: +407.25%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $65.30
Upside: -84.69%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $5.84
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $14.25
Upside: +461.40%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.05
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $0.97
Upside: +32,869.30%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.16
Upside: +19,371.15%